牛叉诊股

[{"date":"2026.01.16","stock":"-4.56","trade":"-0.81","ind":"-0.18"},{"date":"2026.01.15","stock":"-1.23","trade":"-1.14","ind":"0.41"},{"date":"2026.01.14","stock":"-2.30","trade":"-0.56","ind":"0.56"},{"date":"2026.01.13","stock":"5.93","trade":"1.21","ind":"-1.37"},{"date":"2026.01.12","stock":"2.39","trade":"0.28","ind":"1.75"},{"date":"2026.01.09","stock":"-0.32","trade":"1.86","ind":"1.15"},{"date":"2026.01.08","stock":"4.76","trade":"1.15","ind":"-0.51"},{"date":"2026.01.07","stock":"-3.60","trade":"0.44","ind":"0.06"},{"date":"2026.01.06","stock":"1.89","trade":"0.51","ind":"1.40"},{"date":"2026.01.05","stock":"13.22","trade":"3.09","ind":"2.24"},{"date":"2025.12.31","stock":"-0.63","trade":"-0.07","ind":"-0.58"},{"date":"2025.12.30","stock":"-0.25","trade":"-0.48","ind":"0.49"},{"date":"2025.12.29","stock":"-0.99","trade":"-1.13","ind":"-0.49"},{"date":"2025.12.26","stock":"-0.12","trade":"-0.41","ind":"0.54"},{"date":"2025.12.25","stock":"0.37","trade":"0.35","ind":"0.33"},{"date":"2025.12.24","stock":"0.12","trade":"0.28","ind":"0.88"},{"date":"2025.12.23","stock":"-0.25","trade":"-0.30","ind":"0.27"},{"date":"2025.12.22","stock":"1.13","trade":"0.14","ind":"1.47"},{"date":"2025.12.19","stock":"1.14","trade":"1.80","ind":"0.66"},{"date":"2025.12.18","stock":"1.94","trade":"0.51","ind":"-1.29"},{"date":"2025.12.17","stock":"0.78","trade":"0.69","ind":"2.40"}]

北陆药业,深证成指,化学制药指数

压力支撑

该股压力位为9.38元，支撑位为9.12元。

[{"text":"\u538b\u529b\u4f4d","value":"9.38","date":1768492800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"9.12","date":1768492800,"color":"0x0b52a1"}]

多空趋势

多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.2资金面打败了18%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：01月16日 17:19

机构今日流向(万元)	-3399.61	机构5日流向(万元)	-11431.30
机构10日流向(万元)	-7013.74	机构20日流向(万元)	-11520.71

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量增加122.04万股，其中基金净增仓1家，主力净减仓21家，请投资者中长期谨慎为宜。

截止2025-06-30，共16家主力机构（基金11家，一般法人2家，QFII3家），持仓量总计5841.83万股，占流通A股11.81%
其中，基金持仓与2024-12-31相比：
增仓：2家，增持 0.42万股
减仓：1家，减持 2.13万股
新出现在主力名单中：9家，持有590.69万股
从主力名单中消失：30家，原持有167.06万股

消息面诊股

诊断结果：5.5消息面打败了31%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2025-12-24
一般消息	分红转增	不分配不转增	2025-08-26
一般消息	资产重组	公司股权转让	2025-07-08
利好	分红转增	10派0.5元(含税)	2025-04-18

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：7.0行业面打败了85%的股票化学制药行业最新资金流向

近10日来该行业走势明显向上，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势明显向上，接近大盘。

[{"date":"2026.01.16","price":"-0.18","value":"-0.81"},{"date":"2026.01.15","price":"0.41","value":"-1.14"},{"date":"2026.01.14","price":"0.56","value":"-0.56"},{"date":"2026.01.13","price":"-1.37","value":"1.21"},{"date":"2026.01.12","price":"1.75","value":"0.28"},{"date":"2026.01.09","price":"1.15","value":"1.86"},{"date":"2026.01.08","price":"-0.51","value":"1.15"},{"date":"2026.01.07","price":"0.06","value":"0.44"},{"date":"2026.01.06","price":"1.40","value":"0.51"},{"date":"2026.01.05","price":"2.24","value":"3.09"},{"date":"2025.12.31","price":"-0.58","value":"-0.07"},{"date":"2025.12.30","price":"0.49","value":"-0.48"},{"date":"2025.12.29","price":"-0.49","value":"-1.13"},{"date":"2025.12.26","price":"0.54","value":"-0.41"},{"date":"2025.12.25","price":"0.33","value":"0.35"},{"date":"2025.12.24","price":"0.88","value":"0.28"},{"date":"2025.12.23","price":"0.27","value":"-0.30"},{"date":"2025.12.22","price":"1.47","value":"0.14"},{"date":"2025.12.19","price":"0.66","value":"1.80"},{"date":"2025.12.18","price":"-1.29","value":"0.51"},{"date":"2025.12.17","price":"2.40","value":"0.69"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	必贝特	64.98%	-1.92%	5.5分
2	奥锐特	56.86%	12.19%	6.2分
3	前沿生物	40.59%	-8.70%	4.8分
4	上海谊众	38.40%	-0.84%	5.6分
5	新诺威	37.79%	-2.65%	4.9分
6	键凯科技	34.32%	7.72%	5.0分
7	宏源药业	33.39%	2.13%	4.4分
8	亚虹医药	29.37%	11.68%	5.9分
9	悦康药业	29.13%	-10.07%	5.3分
10	多瑞医药	28.95%	12.98%	5.5分
11	微芯生物	26.81%	2.74%	5.9分
12	北陆药业	18.84%	-0.11%	5.7分
13	山河药辅	18.26%	13.18%	4.8分
14	迪哲医药	18.07%	1.65%	4.9分
15	福元医药	17.97%	-9.55%	5.7分
16	东亚药业	17.33%	-1.85%	4.5分
17	科源制药	17.26%	6.07%	4.9分
18	翰宇药业	16.05%	5.61%	5.5分
19	汇宇制药	15.77%	-4.55%	5.4分
20	华邦健康	15.74%	11.25%	5.6分
21	兴齐眼药	14.88%	3.79%	6.0分
22	富士莱	14.33%	4.42%	5.3分
23	富祥药业	14.13%	1.91%	5.1分
24	尔康制药	14.12%	9.09%	5.6分
25	联环药业	13.83%	-4.88%	5.2分
26	一品红	13.56%	1.34%	5.2分
27	百济神州	13.15%	-1.88%	5.8分
28	润都股份	13.05%	9.84%	5.5分
29	海森药业	12.17%	6.25%	5.4分
30	海翔药业	11.84%	-9.19%	4.9分
31	-	11.72%	6.51%	分
32	泰恩康	11.46%	-4.41%	4.9分
33	诚意药业	11.41%	2.54%	5.3分
34	金陵药业	11.26%	-1.78%	5.2分
35	广济药业	11.26%	-4.59%	6.1分
36	仟源医药	11.08%	0.83%	5.1分
37	花园生物	10.79%	1.76%	5.7分
38	本立科技	10.76%	3.02%	5.4分
39	力生制药	10.42%	-0.85%	5.2分
40	民生健康	10.30%	-0.37%	4.8分
41	川宁生物	9.96%	-0.54%	4.9分
42	盟科药业	9.93%	-2.97%	5.3分
43	溢多利	9.79%	2.51%	4.9分
44	司太立	9.15%	1.20%	5.2分
45	奥赛康	9.13%	-5.15%	5.1分
46	昂利康	8.72%	-2.26%	5.1分
47	东诚药业	8.65%	-0.34%	5.3分
48	海辰药业	8.51%	3.26%	4.8分
49	海欣股份	8.22%	-3.08%	4.7分
50	宣泰医药	8.02%	2.14%	5.3分
51	南新制药	7.97%	-2.25%	4.8分
52	普洛药业	7.89%	7.76%	5.4分
53	共同药业	7.76%	0.43%	5.1分
54	西点药业	7.70%	0.13%	5.4分
55	天宇股份	7.20%	-0.55%	5.6分
56	贝达药业	7.19%	-2.10%	4.9分
57	新天地	7.09%	1.70%	4.8分
58	舒泰神	6.94%	-7.40%	4.7分
59	奥翔药业	6.82%	-2.34%	4.9分
60	小方制药	6.80%	1.35%	5.5分
61	美诺华	6.65%	-1.94%	5.4分
62	国邦医药	6.49%	-3.13%	5.0分
63	赛托生物	6.43%	0.28%	4.5分
64	莱美药业	6.29%	-7.37%	4.6分
65	威尔药业	6.05%	1.49%	5.4分
66	纳微科技	5.49%	-0.81%	6.0分
67	中关村	5.38%	1.39%	5.0分
68	赛分科技	5.38%	5.49%	5.8分
69	亿帆医药	5.29%	-2.56%	5.4分
70	拓新药业	5.14%	0.95%	4.6分
71	金城医药	5.12%	2.15%	4.9分
72	博瑞医药	4.75%	-5.81%	4.8分
73	立方制药	4.67%	-2.25%	6.1分
74	复旦张江	4.47%	-2.15%	4.7分
75	新和成	4.29%	-1.02%	5.6分
76	亚太药业	4.26%	-5.78%	4.8分
77	海普瑞	4.21%	-1.46%	5.3分
78	汉商集团	4.11%	1.80%	5.8分
79	-	4.10%	2.33%	分
80	海正药业	4.06%	-1.50%	5.6分
81	国药现代	4.01%	0.38%	5.4分
82	双鹭药业	3.98%	-3.44%	5.4分
83	益方生物	3.93%	-9.76%	4.9分
84	德展健康	3.64%	0.00%	4.7分
85	卫信康	3.64%	-1.07%	5.4分
86	千红制药	3.57%	-2.17%	5.1分
87	新华制药	3.50%	1.12%	5.3分
88	永安药业	3.48%	-2.27%	4.9分
89	首药控股	3.44%	-5.06%	4.3分
90	易明医药	3.33%	-0.65%	5.0分
91	丽珠集团	3.32%	-2.10%	5.2分
92	-	3.32%	0.00%	分
93	灵康药业	3.28%	-1.87%	5.1分
94	誉衡药业	3.25%	-0.63%	5.5分
95	-	3.24%	1.96%	分
96	圣诺生物	3.17%	-3.88%	5.9分
97	吉贝尔	3.04%	-4.56%	5.0分
98	ST天圣	2.95%	-0.41%	4.5分
99	科伦药业	2.79%	-5.38%	4.5分
100	-	2.78%	0.00%	分
101	辰欣药业	2.77%	-3.45%	4.9分
102	恒瑞医药	2.72%	-2.88%	5.2分
103	海思科	2.71%	-4.20%	5.3分
104	复星医药	2.68%	-0.22%	4.7分
105	金石亚药	2.64%	0.93%	4.8分
106	丰原药业	2.55%	-0.77%	5.5分
107	-	2.48%	0.17%	分
108	九典制药	2.41%	-0.32%	4.7分
109	-	2.22%	1.13%	分
110	亨迪药业	2.17%	-1.32%	3.8分
111	健友股份	2.17%	-1.67%	5.0分
112	-	2.07%	1.74%	分
113	苑东生物	1.92%	-8.64%	5.4分
114	仙琚制药	1.87%	0.33%	5.2分
115	浙江医药	1.83%	-0.85%	5.2分
116	ST人福	1.82%	1.26%	5.1分
117	哈三联	1.79%	1.16%	4.6分
118	莎普爱思	1.76%	-2.08%	3.8分
119	同和药业	1.31%	0.26%	4.1分
120	华仁药业	1.26%	-1.53%	5.1分
121	能特科技	1.20%	-2.32%	5.4分
122	鲁抗医药	1.20%	-1.39%	5.4分
123	健康元	1.03%	-1.50%	5.3分
124	津药药业	0.98%	-1.20%	5.0分
125	华北制药	0.72%	-1.59%	5.2分
126	华润双鹤	0.65%	-0.59%	5.4分
127	北大医药	0.63%	-1.83%	5.1分
128	神奇制药	0.49%	-2.07%	5.1分
129	艾力斯	0.14%	-6.33%	5.3分
130	海南海药	-0.15%	-9.07%	4.9分
131	东北制药	-0.19%	-2.05%	5.6分
132	天新药业	-0.22%	1.04%	4.0分
133	华海药业	-0.35%	-8.44%	5.1分
134	*ST景峰	-0.40%	-3.08%	5.1分
135	海创药业	-0.51%	-5.83%	4.8分
136	-	-0.59%	0.77%	分
137	康芝药业	-0.87%	-10.84%	4.7分
138	ST诺泰	-0.91%	-1.72%	4.9分
139	罗欣药业	-1.22%	-3.58%	4.5分
140	*ST赛隆	-1.36%	-1.50%	4.3分
141	哈药股份	-1.41%	-1.13%	4.9分
142	广生堂	-1.99%	-8.51%	4.2分
143	华特达因	-2.22%	-1.92%	5.0分
144	恩华药业	-2.25%	-1.14%	5.2分
145	华纳药厂	-2.45%	-9.02%	4.9分
146	河化股份	-2.50%	0.82%	5.8分
147	华东医药	-3.40%	-2.40%	4.5分
148	福安药业	-4.03%	0.89%	4.4分
149	ST复华	-4.17%	-2.04%	4.7分
150	泽璟制药	-5.14%	-4.77%	5.1分
151	*ST三圣	-5.21%	-2.02%	4.5分
152	通化金马	-5.31%	4.18%	4.6分
153	京新药业	-6.75%	-9.65%	5.4分
154	信立泰	-7.43%	-3.97%	5.6分
155	常山药业	-9.08%	-1.49%	4.4分
156	百利天恒	-10.36%	-8.36%	3.9分
157	向日葵	-40.41%	-37.48%	3.8分

<上一页 1 2 3 4 5...27 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：6.1基本面打败了58%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值一般。

个股深一度

潜在高分红能力：弱（35分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 92/217 ， 81/217。

[{"date":"2025-09-30","value":"2.28","vol":"1.51"},{"date":"2025-06-30","value":"1.78","vol":"1.23"},{"date":"2025-03-31","value":"0.87","vol":"-0.14"},{"date":"2024-12-31","value":"0.82","vol":"19.62"},{"date":"2024-09-30","value":"1.47","vol":"4.62"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	2.28	1.78	0.87	0.82	1.47
行业(%)	1.51	1.23	-0.14	19.62	4.62

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"45.87","vol":"49.36"},{"date":"2025-06-30","value":"47.07","vol":"49.33"},{"date":"2025-03-31","value":"45.45","vol":"49.14"},{"date":"2024-12-31","value":"47.67","vol":"50.78"},{"date":"2024-09-30","value":"50.04","vol":"50.61"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	45.87	47.07	45.45	47.67	50.04
行业(%)	49.36	49.33	49.14	50.78	50.61

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 22/217 ， 19/217。

[{"date":"2025-09-30","value":"19.59","vol":"142.98"},{"date":"2025-06-30","value":"23.27","vol":"79.25"},{"date":"2025-03-31","value":"36.23","vol":"-0.67"},{"date":"2024-12-31","value":"10.42","vol":"18.07"},{"date":"2024-09-30","value":"12.30","vol":"45.94"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	19.59	23.27	36.23	10.42	12.30
行业(%)	142.98	79.25	-0.67	18.07	45.94

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"81.10","vol":"-3.26"},{"date":"2025-06-30","value":"53.35","vol":"58.57"},{"date":"2025-03-31","value":"26.14","vol":"-11.22"},{"date":"2024-12-31","value":"119.02","vol":"-22.02"},{"date":"2024-09-30","value":"1156.34","vol":"-34.66"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	81.10	53.35	26.14	119.02	1156.34
行业(%)	-3.26	58.57	-11.22	-22.02	-34.66

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 76/217 ， 95/217。

[{"date":"2025-09-30","value":"0.28","vol":"0.31"},{"date":"2025-06-30","value":"0.19","vol":"0.21"},{"date":"2025-03-31","value":"0.09","vol":"0.10"},{"date":"2024-12-31","value":"0.34","vol":"0.43"},{"date":"2024-09-30","value":"0.25","vol":"0.33"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.28	0.19	0.09	0.34	0.25
行业(次)	0.31	0.21	0.10	0.43	0.33

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.29","vol":"1.94"},{"date":"2025-06-30","value":"0.84","vol":"1.30"},{"date":"2025-03-31","value":"0.43","vol":"0.66"},{"date":"2024-12-31","value":"1.70","vol":"3.19"},{"date":"2024-09-30","value":"1.28","vol":"2.12"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	1.29	0.84	0.43	1.70	1.28
行业(次)	1.94	1.30	0.66	3.19	2.12

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"25.02","vol":"4.43"},{"date":"2025-06-30","value":"4.20","vol":"2.74"},{"date":"2025-03-31","value":"15.70","vol":"-26.98"},{"date":"2024-12-31","value":"10.03","vol":"-373.99"},{"date":"2024-09-30","value":"5.87","vol":"-9.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	25.02	4.20	15.70	10.03	5.87
行业	4.43	2.74	-26.98	-373.99	-9.47

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.15","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.01","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	2.15	-	1.01	-
行业	0.00	1.73	0.00	2.00	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 12/217 ， 57/217。

[{"date":"2025-09-30","value":"2.22","vol":"3.50"},{"date":"2025-06-30","value":"2.27","vol":"3.69"},{"date":"2025-03-31","value":"2.50","vol":"3.61"},{"date":"2024-12-31","value":"2.57","vol":"3.36"},{"date":"2024-09-30","value":"2.71","vol":"3.67"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	2.22	2.27	2.50	2.57	2.71
行业	3.50	3.69	3.61	3.36	3.67

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.52","vol":"2.75"},{"date":"2025-06-30","value":"1.58","vol":"2.90"},{"date":"2025-03-31","value":"1.79","vol":"2.83"},{"date":"2024-12-31","value":"1.73","vol":"2.65"},{"date":"2024-09-30","value":"1.92","vol":"2.93"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	1.52	1.58	1.79	1.73	1.92
行业	2.75	2.90	2.83	2.65	2.93

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 81/217 ， 78/217。

[{"date":"2025-09-30","value":"26.47","vol":"33.63"},{"date":"2025-06-30","value":"41.85","vol":"33.66"},{"date":"2025-03-31","value":"42.49","vol":"33.90"},{"date":"2024-12-31","value":"38.56","vol":"34.07"},{"date":"2024-09-30","value":"38.62","vol":"32.87"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	26.47	41.85	42.49	38.56	38.62
行业(%)	33.63	33.66	33.90	34.07	32.87

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.39","vol":"0.94"},{"date":"2025-06-30","value":"0.79","vol":"0.88"},{"date":"2025-03-31","value":"0.81","vol":"1.47"},{"date":"2024-12-31","value":"0.69","vol":"0.84"},{"date":"2024-09-30","value":"0.69","vol":"0.73"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.39	0.79	0.81	0.69	0.69
行业(%)	0.94	0.88	1.47	0.84	0.73

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"1.26","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.11","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.72","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.14","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[北陆药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]